Mark E Gurney

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 4

Top Topics

Multiple Sclerosis

Placebo Controlled

Positron Emission Tomography

Top Venues

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Nature medicine

JMIR research protocols

ACS chemical neuroscience

Tetra Therapeutics (United States)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tetra Therapeutics (United States) Nov 01 2011

United States

Chairman & CEO

Publications

Elizabeth M Berry-Kravis, Mark D Harnett, Scott A Reines, Melody A Reese, Lauren E Ethridge, Abigail H Outterson, Claire Michalak, Jeremiah Furman, Mark E Gurney
Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial. Nature medicine 27 (5) (2021)
Yuichi Wakabayashi, Sanjay Telu, Rachel M Dick, Masahiro Fujita, Maarten Ooms, Cheryl L Morse, Jeih-San Liow, Jinsoo S Hong, Robert L Gladding, Lester S Manly, Sami S Zoghbi, Xuesheng Mo, Emily C D'Amato, Janice A Sindac, Richard A Nugent, Brian E Marron, Mark E Gurney, Robert B Innis, Victor W Pike
Discovery, Radiolabeling, and Evaluation of Subtype-Selective Inhibitors for Positron Emission Tomography Imaging of Brain Phosphodiesterase-4D. ACS chemical neuroscience 11 (9) (2020)
Julie M Cowie, Mark E Gurney
The Use of Facebook Advertising to Recruit Healthy Elderly People for a Clinical Trial: Baseline Metrics. JMIR research protocols 7 (1) (2018)
Chong Zhang, Ying Xu, Anirudh Chowdhary, David Fox, Mark E Gurney, Han-Ting Zhang, Benjamin D Auerbach, Richard J Salvi, Mingxin Yang, Gaowen Li, James M O'Donnell
Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 43 (11) (2018)